The evidence supports over-the-counter access to progestin-only pills: A research summary

March 20, 2023 8:03 AM | Becca Liebers (Administrator)

Free the Pill | March 16, 2023

HRA Pharma has submitted an application to the FDA for an over the counter (OTC) progestin-only birth control pill (POP). If approved, Opill would be the first OTC birth control pill available in the United States. This research summary highlights the safety and efficacy of POPs, experiences with and interest in using them, and the challenges and barriers to accessing birth control pills in the current prescription-only environment.

Read more.

Powered by Wild Apricot Membership Software